PAREXEL International Corporation (PRXL) During the most recent session, the shares traded at 0.1 points or 0.16% higher at $64.25. The money flow data is unimpressive with the net money flow value of $(-3.99) million. As per the intraday data, the upticks measured $4.45 million and the downticks measured $8.44 million. As a result, the up/down ratio registered a value of 0.53. The shares have seen -1.59% price change for the week.A block trade also made an entry with $0 million flowing in through upticks while $1.71 million flew out through downticks. The block tradeoff had the up/down ratio of 0. The net money flow for this big transaction was $(-1.71) million.
Based on the Stock Research reports from financial advisors, there are 1 Analysts recommending as a Strong Buy, Investors should also note that 10 Stock brokerage firms are recommending to Hold the stock for short term. There are 3 Analysts recommending as a Strong Sell. PAREXEL International Corporation (NASDAQ:PRXL) witnessed a decline in the market cap on Thursday as its shares dropped 0.78% or 0.5 points. After the session commenced at $63.77, the stock reached the higher end at $64.32 while it hit a low of $63.04. With the volume soaring to 1,670,853 shares, the last trade was called at $63.65. The company has a 52-week high of $72.32. The company has a market cap of $3,243 million and there are 50,954,585 shares in outstanding. The 52-week low of the share price is $51.16.
PAREXEL International Corporation has a Price to Earnings ratio of 19.13 for the trailing twelve month period. The price to book ratio of the company for the most recent quarter is 6.55. For the Most Recent Fiscal Year, PAREXEL International Corporation has a price to cash ratio of 12.31. For the Trailing twelve month period, company showed a Net Profit Margin of 6.34% and Return on Equity of the stock is 29.92%. According to the corporate earnings calendar, PAREXEL International Corporation will release next earnings on Apr 26, 2017 with an estimated EPS consensus of $0.73. Based on the consensus of stock financial advisors the stock has a price target of $64.45. Current year estimate on EPS consensus is $3.25. The Estimated EPS rate for Long term growth is $13.5. For Dividend Investing Stock Market Traders PAREXEL International Corporation has a Dividend Yield of 0% with an Annual Dividend of $0. It has a Payout Ratio of 0 and the change in Dividend payout ratio is 0.
Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.